Holiday thank-you coupon: enjoy 10% off all products

MVEV Env Specific Neutra™ Antibody Products

Product list

Are you currently facing hurdles in your flavivirus research, such as cross-reactivity within the Japanese encephalitis virus serocomplex, low neutralization potency in assay development, or a lack of reliable structural probes? Creative Biolabs'MVEV Env specific Neutra™ antibody products help you achieve high-affinity, validated results and accelerate your therapeutic pipeline through our advanced hybridoma technology and innovative protein engineering platforms.

Introduction to MVEV Env

Murray Valley encephalitis virus Envelope protein (MVEV Env) is the principal surface glycoprotein of the Murray Valley encephalitis virus, a member of the Flaviviridae family. As the primary target of the host immune system, MVEV Env is essential for the virus's ability to infect host cells. It is expressed as a precursor (prM-E) during viral maturation and is eventually cleaved to form the mature, infectious virion surface.

  • Structure

The architecture of MVEV Env is characterized by a head-to-tail homodimeric arrangement on the mature viral membrane. Each monomer is composed of three distinct beta-sheet rich domains: Domain I (DI), the central structural scaffold; Domain II (DII), which contains the highly conserved internal fusion loop; and Domain III (DIII), an immunoglobulin-like fold that protrudes from the viral surface. This domain-based structure is critical for the protein's ability to undergo the dramatic conformational shifts required for membrane fusion.

Location of genotype-defining amino acid residues and motifs in the ectodomain of the MVEV Env protein. (OA Literature)Fig.1 The ectodomain of the MVEV Env protein and the locations of amino acids.1

  • Function

The primary function of MVEV Env is to facilitate viral entry into the host cell. It mediates initial attachment to specific cell-surface receptors and, following endocytosis, orchestrates the fusion of the viral envelope with the endosomal membrane. This fusion is triggered by the acidic environment of the endosome, causing the Env dimers to reorganize into stable trimers, which expose the fusion peptide and allow the viral genome to enter the cytoplasm.

  • Related Signaling Pathways
    • Receptor-Mediated Endocytosis: MVEV Env interacts with attachment factors like heparan sulfate and specific entry receptors to trigger clathrin-dependent endocytic pathways, initiating the internal signaling required for successful viral uptake into the host cell cytoplasm.
    • pH-Dependent Conformational Signaling: The protein acts as a molecular sensor for low pH within the maturing endosome, initiating a structural signaling cascade that leads to irreversible membrane hemifusion and the subsequent release of the viral nucleocapsid.
    • Clathrin-Mediated Endocytosis Activation: Upon binding to high-affinity surface receptors, MVEV Env triggers the recruitment of adaptor proteins and clathrin heavy chains, stimulating a signaling flux that induces membrane curvature and the formation of specialized endocytic pits for viral internalization.
    • Host Immune Evasion Signaling: MVEV Env can modulate the host's innate immune signaling by interfering with the Type I Interferon pathway, effectively suppressing the activation of interferon-stimulated genes (ISGs) and creating a more permissive cellular environment for rapid viral replication.
    • Immune Evasion and Enhancement Pathways: By shielding conserved epitopes or utilizing "decoy" non-neutralizing antibodies (antibody-dependent enhancement), MVEV Env can influence the host's innate immune signaling, potentially exacerbating inflammation and facilitating the infection of myeloid cells via Fc-receptor mediated entry.
  • Related Diseases

MVEV Env is the critical factor in the pathogenesis of Murray Valley Encephalitis (MVE). This disease ranges from mild febrile illness to severe, potentially fatal neuroinvasive disease characterized by encephalitis, permanent neurological sequelae, and high mortality rates in symptomatic patients.

Applications of MVEV Env Neutralizing Antibodies

  • Therapeutic Monoclonal Development

Neutralizing antibodies targeting the MVEV Env DIII are being investigated as potent passive immunotherapies. By blocking the receptor-binding site, these antibodies prevent viral attachment, significantly reducing viral load and preventing neuroinvasion in pre-clinical models.

  • High-Specificity Diagnostic Assays

Due to the high sequence homology among flaviviruses, anti-MVEV Env antibodies are essential for developing IgM-capture ELISAs and lateral flow immunochromatographic assays that can accurately differentiate MVEV from West Nile or Kunjin viruses.

  • Vaccine Efficacy Assessment

In vaccine development, MVEV Env antibodies serve as the "gold standard" reagents in Plaque Reduction Neutralization Tests (PRNT). They allow researchers to quantify the neutralizing breadth of the vaccine-induced immune response and identify correlates of protection.

  • Viral Epitope Mapping

Researchers utilize these antibodies to perform escape mutant analysis. By identifying which residues on MVEV Env allow the virus to bypass neutralization, scientists can better understand viral evolution and design more robust, "escape-proof" immunogens.

  • Bio-Surveillance and Vector Control

Neutralizing antibodies are integrated into biosensors for environmental monitoring. These tools allow for the rapid detection of MVEV in mosquito populations (e.g., Culex annulirostris), providing critical data for public health authorities to implement timely vector control measures.

  • Neurotropic Mechanism Studies

By labeling anti-MVEV Env antibodies with fluorescent markers, scientists can track the movement of the virus through the blood-brain barrier and into specific neural pathways, providing insights into how the virus causes cerebral inflammation.

  • Structural Biology Probes

These antibodies are used as "chaperones" in Cryo-EM and X-ray crystallography to stabilize specific conformational states of the MVEV Env protein, revealing the molecular details of the fusion process.

Our Anti-MVEV Env Antibodies

Creative Biolabs provides a comprehensive catalog of high-performance antibodies specifically designed to target the MVEV Env protein with unparalleled affinity. Our selection includes diverse clones that have been rigorously validated across multiple platforms to ensure reliability in both basic research and clinical development settings.

  • Broad Epitope Coverage: Our portfolio includes antibodies targeting DI, DII, and the highly potent DIII regions, allowing for comprehensive mapping of the viral surface.
  • Strict Specificity: Each Neutra™ product is screened against related flaviviruses to ensure minimal cross-reactivity, making them ideal for differential diagnostics.
  • Multi-Platform Compatibility: These antibodies are optimized for high-sensitivity Western Blotting (WB), Flow Cytometry, and Immunohistochemistry (IHC) on infected tissues.
  • High Neutralization Potency: We offer specific clones with low IC50 values, suitable for in vitro neutralization assays and in vivo passive protection studies.
  • Custom Conjugation Services: Our MVEV Env antibodies can be provided with various labels, including biotin and HRP, to suit your specific experimental design.

Creative Biolabs remains your premier partner for high-quality MVEV Env specific Neutra™ antibody products, offering the precision and reliability needed to overcome the complexities of flavivirus research. For detailed technical specifications, bulk pricing, or to discuss a custom project, please contact our team today—our experts are ready to provide a prominent consultation to help you achieve your research goals.

Reference

  1. Williams, David T., et al. "The molecular epidemiology and evolution of Murray Valley encephalitis virus: recent emergence of distinct sub-lineages of the dominant genotype 1." PLOS Neglected Tropical Diseases 9.11 (2015): e0004240. Distributed under Open Access license CC BY 4.0, without modification. https://doi.org/10.1371/journal.pntd.0004240
Show More Close

Inquiry

Recombinant Anti-MVEV Env Antibody (V3S-1022-YC4728) (CAT#: V3S-1022-YC4728)

Target: MVEV Env

Host Species: Mouse

Target Species: Murray Valley encephalitis virus (MVEV),

Application: WB,

For research use only, not directly for clinical use.


banner banner
© 2026 Creative Biolabs. All Rights Reserved.
antibody
ISO 9001 Certified - Creative Biolabs Quality Management System.
Online Inquiry